Immunoglobulin (Ig) refers to a globulin that has antibody (AB) activity or chemical structure that is similar to an antibody molecule. Immunoglobulin is a tetrapeptide chain structure formed by two identical light chains and two identical heavy chains linked by interchain disulfide bonds. Immunoglobulins are divided into five categories, namely immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin M (IgM), immunoglobulin D (IgD), and immunoglobulin E (IgE).
Immunoglobulins are mainly classified.
Source**: Joint Research Industry Consulting (Joint Research Network).
Tetanus passive immunization products are the main way to prevent tetanus in China, tetanus human immunoglobulin (HTIG) is directly extracted from the plasma of healthy people who have been immunized, which has the advantages of good efficacy, almost no allergies, and no skin test. In 2022, the batch issuance of human immunoglobulin for tetanus in China will be 688860,000 bottles, a year-on-year increase of 668%。
From 2016 to 2022, the domestic tetanus human immunoglobulin market was issued in batches.
Source**: Joint Research Industry Consulting (Joint Research Network).
In 2022, the higher batches of tetanus human immunoglobulin enterprises in China are Hualan Biotech, Taibang Biotech, Tiantan Biotech, Pailin Biotech, Shanghai RAAS, Weiguang Biotech, Boffin Innovation, etc., of which 51 batches of Hualan Biotech were approved, 31 batches of Taibang Biotech were approved, 28 batches of Tiantan Biotech were approved, and 20 batches of Pailin Biotech were approved.
The pattern of domestic tetanus human immunoglobulin enterprises in 2022.
Source**: Joint Research Industry Consulting (Joint Research Network).
For more comprehensive data and in-depth analysis of the tetanus human immunoglobulin industry, please search and collect the "2023-2029 China Tetanus Human Immunoglobulin Industry Panorama Survey and Future Development Trend Report" exclusively released by the joint research network. 2023-2029 China Tetanus Human Immunoglobulin Industry Panorama Survey and Future Development Trend Report is an industry report independently researched and released by the Joint Research Industry Research Institute, and is an annual special report in the field of tetanus human immunoglobulin. The "2023-2029 China Tetanus Human Immunoglobulin Industry Panorama Survey and Future Development Trend Report" starts from the perspectives of tetanus human immunoglobulin development environment, market operation situation, market segmentation, regional market, and competition pattern, analyzes the future market trend of the tetanus human immunoglobulin industry, excavates the development potential of the tetanus human immunoglobulin industry, and promotes the high-quality development of the tetanus human immunoglobulin industry.